425: Strive CEO Reposts Semler Scientific Merger Update

Strive CEO Matthew Cole reposted a communication on X.com regarding the proposed business combination with Semler Scientific, Inc., emphasizing forward-looking statements and associated risks.

Summary

• A communication was reposted by Matthew Cole, Chief Executive Officer of Strive, Inc. on September 29, 2025, concerning the proposed business combination with Semler Scientific, Inc.
• The communication serves as a cautionary statement regarding forward-looking statements related to the proposed transaction.
• It highlights inherent risks and uncertainties associated with the merger, including the realization of strategic and financial benefits, the timing of closing, and potential integration challenges.
• Strive intends to file a Registration Statement on Form S-4 with the SEC to register the Class A common stock to be issued in connection with the proposed transaction.
• This Registration Statement will include an Information Statement/Proxy Statement/Prospectus, which will be sent to Semler Scientific stockholders to seek their approval.
• Investors and stockholders are urged to read the Registration Statement and other relevant documents filed with the SEC before making any voting or investment decisions.
• Strive, Semler Scientific, and certain of their respective directors, executive officers, and employees may be deemed participants in the solicitation of proxies from Semler Scientific stockholders.

Sentiment

Score: 5

Explanation: The filing is a standard cautionary statement for a proposed merger, heavily emphasizing risks and forward-looking disclaimers. While the underlying merger could be positive, the document itself is neutral to slightly cautious in tone, focusing on potential pitfalls rather than immediate benefits.

Positives

• The proposed transaction is anticipated to bring strategic and financial benefits to the combined company.
• Management expects to successfully integrate the combined businesses.

Risks

• The occurrence of any event, change, or other circumstances that could give rise to the right of one or both companies to terminate the merger agreement.
• The possibility that the proposed transaction does not close when expected or at all because conditions to closing are not received or satisfied on a timely basis or at all.
• The outcome of any legal proceedings that may be instituted against Strive, Semler Scientific, or the combined company.
• The possibility that the anticipated benefits of the proposed transaction, including cost savings and strategic gains, are not realized when expected or at all.
• Changes in, or problems arising from, the implementation of Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets.
• General economic and market conditions, interest and exchange rates, monetary policy, and laws and regulations and their enforcement could impact the transaction.
• The integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The proposed transaction may be more expensive or take longer to complete than anticipated due to unexpected factors or events.
• Diversion of management's attention from ongoing business operations and opportunities.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction.
• Potential adverse reactions of Strive's or Semler Scientific's customers or changes to business or employee relationships, including those resulting from the announcement or completion of the proposed transaction.
• Changes in Strive's or Semler Scientific's share price before closing.
• Other factors, including unknown or unpredictable factors, could harm Strive, Semler Scientific, or the combined company's results.

Future Outlook

The proposed transaction is expected to yield strategic and financial benefits, including successful integration of the combined businesses. The timing of the closing of the proposed transaction is also an area of expectation, though subject to significant risks and uncertainties.

Management Comments

• Matthew Cole, Chief Executive Officer of Strive, Inc., reposted the communication on X.com regarding the proposed business combination with Semler Scientific, Inc.

Industry Context

The mention of 'risks associated with Bitcoin and other digital assets' and 'implementation of Bitcoin treasury strategies' suggests that the proposed combined entity may be engaging with or exposed to the cryptocurrency market, reflecting a broader trend of companies exploring digital asset integration into their financial strategies.

Legal Proceedings

• The outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company is identified as a risk factor for the proposed transaction.

Related Party Transactions

• Information about Semler Scientific's transactions with related persons is set forth in its definitive proxy statement for its 2025 Annual Meeting of Stockholders, filed on July 17, 2025.

Stakeholder Impact

• Shareholders of Strive may experience dilution due to the issuance of additional Class A common stock in connection with the proposed transaction.
• Potential adverse reactions from customers of Strive or Semler Scientific could occur.
• Changes to business or employee relationships for both companies are a possibility.

Next Steps

• Strive intends to file a Registration Statement on Form S-4 with the SEC.
• A definitive Information Statement/Proxy Statement/Prospectus will be sent to the stockholders of Semler Scientific.
• Semler Scientific stockholders will be asked to approve the proposed transaction.

Key Dates

Keywords

Strive Inc., Semler Scientific Inc., Merger, Business Combination, SEC Filing, Form 425, Bitcoin Treasury, Forward-Looking Statements, Acquisition, Corporate Governance